The Role of Real-world Evidence in the Evolving Treatment Landscape of Multiple Myeloma
A Q&A With Robert M. Rifkin, MD, FACP
A Q&A With Faith Davies, MD, MRCP, MRCPATH, FRCPATH
Advertisement
Advertisement
Trending on AJMC
1
Once-Monthly Maridebart Cafraglutide Shows Up to 16% Weight Loss
2
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
3
52-Week VERIFY Data Show Rusfertide Brings Sustained Responses in PV
4
In CLL, Fixed-Duration Venetoclax Combos Are Equal to Continuous Ibrutinib in Head-to-Head Comparison
5
